ANALYSTS
-
Teleflex raises 2024 profit forecast on medical device demand
Investor expectations around the performance of medical device makers have been heightened since last November due to higher demand for procedures, especially among older adults, that were delayed during the COVID-19 pandemic.
-
Merck second quarter tops Street view on strong Keytruda sales
-
J&J beats Wall Street estimates on strong drug sales
-
Increased testing, opening economy, complacency among people behind Covid-19 case surge: Experts
-
Health & hygiene on everyone’s mind. Why should D-Street be any different?
-
Analysts slash Sanofi target over Ankleshwar plant sale
Advertisement
Advertisement